Posts Tagged ‘NIH’
Reason for Optimism: The HEAL Initiative Prepares for the Future
The publication of a roadmap for HEAL research earlier this year sets the stage for 2026 and beyond.
Read MoreHEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
From the NIH website: The purpose of this HEAL Initiative program is to: (1) support basic and mechanistic pain research from R15-eligible undergraduate-focused serving institutions, health professional schools or graduate schools; (2) promote integrated, interdisciplinary research partnerships between Principal Investigators (PIs) from R15-eligible institutions and investigators from U.S. domestic institutions; and (3) enhance the pain research…
Read MoreNew NIH Policy on Animal Models in Research: What Does It Mean for the Migraine Field?
The National Institutes of Health has announced a plan to move away from animal models towards human-based approaches instead. Scientists who spoke to Migraine Science Collaborative say the new policy could slow the development of new headache and pain treatments, though ultimate impacts remain unclear.
Read MoreNew US Government Policies Hit the Migraine Field
Members of the migraine community express uncertainty about how the new directives will play out.
Read MoreHEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
From NIH: Introduction This study is part of the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative® , to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management. More information about…
Read More5th Annual NIH HEAL Initiative Scientific Meeting
The NIH HEAL Initiative® will convene the 5th Annual NIH HEAL Initiative Scientific Meeting on Wednesday and Thursday, February 7-8, 2024.
Read MoreNIH HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics.
Read MoreNational Institutes of Health (NIH) HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery
The purpose of this Notice of Special Interest (NOSI) is to encourage the development, validation, and replication of animal models that recapitulate the phenotypic and physiologic characteristics of a defined pain type/indication and/or disease-associated pain condition and endpoints or outcome measures that can be used therein.
Read MoreAdvocating for Migraine Research, Overcoming Stigma, and Improving Treatment: A Chat with Robert Shapiro
Dr. Shapiro discusses how he got into migraine research, the problems of migraine stigma and research underfunding, the use of CGRP drugs, and, interestingly, why migraine may actually be protective against COVID.
Read More